Reports

Browse current and previous editions of Switzer Report

Monday Edition, 24 August 2026
Switzer on Saturday, 22 August 2026
Peter Switzer

The bond market joins Iran as a worrying headwind

Peter Switzer · August 22, 2026

Just when you think it makes sense to be cautious with equities, you can count on the Yanks on Wall Street to find a silver lining inside a dark cloud. And this sounds like a fair call, with all US stock market indexes heading for a 'green on the screen' Friday finish, though for the week it was an 'in-the-red' story.

Switzer on Saturday Premium
Thursday Edition, 20 August 2026
Paul Rickard

Questions of the Week (20 August 2026)

Paul Rickard · August 20, 2026

What are the advantages of an equal-weighted ETF? Is the takeover of plumbing supplies group Reliance Worldwide (RWC) a “done deal”? Have the brokers raised their target prices for CSL following a better-than-expected result? When does BHP trade ex-dividend? Is it fully franked?

Investing Premium
Maureen Jordan

“HOT” stock: Woodside Energy (WDS)

Maureen Jordan · August 20, 2026

Michael Gable, Managing Director of Fairmont Equities, says the biggest oil and gas stock on the Australian market, Woodside Energy (WDS), is breaking out of consolidation and is on the cusp of a significant run higher.

Investing Premium
Monday Edition, 17 August 2026
Peter Switzer

Will these “forgiven” stocks justify investor support?

Peter Switzer · August 17, 2026

Over the next two weeks we will get the earnings show and tell from a number of companies that have had shockers over the past year or so but recently they have been ‘forgiven’ or at least trusted to perform better than expected. Given the fact that many such as Xero, WiseTech, CSL and others have picked up a get-out-of jail card of late, these companies will need to deliver something positive, or at least not give any new bad news.

Investing Premium
Paul Rickard

Is Telstra back in the buy zone?

Paul Rickard · August 17, 2026

I have been a long-time fan of Telstra (TLS), not because it is a great company – because it is not – but because it is the dominant player providing services that none of us can go without. Further, as an investor, it is a super defensive stock which has reliable earnings, those earnings have been steadily increasing and it pays a good, almost fully franked dividend, which has also been increasing.

Investing Premium
James Dunn

Regenerative medicine: two attractive buys in a fascinating niche

James Dunn · August 17, 2026

It is a very esoteric niche on the ASX, but regenerative medicine is a fascinating area. ASX-listed companies PolyNovo, AVITA Medical and AROA Biosurgery all focus on regenerative medicine and soft-tissue repair, targeting severe burns, trauma and complex wounds, using active biological or structural reconstruction.

Investing Premium
Switzer on Saturday, 15 August 2026
Peter Switzer

Iran is trumping our market

Peter Switzer · August 15, 2026

US stocks overall are heading for the third winning week in a row, and you can thank the spectacular earnings reports of most companies that have been on 'show-and-tell' over the past three weeks. Given the prevailing concerns about the future because of Iran's impact on oil prices, inflation and interest rates, the fact that FactSet reports that more than 90% of S&P 500 companies have posted second-quarter results, and earnings growth from the year-earlier period is tracking around 50%.

Switzer on Saturday Premium

You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.